Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change. [electronic resource]
Publication details: Osteoporosis and sarcopenia Mar 2017Description: 45-52 p. digitalISSN:- 2405-5263
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.